Bovilis BTV8

RSS
Withdrawn

This medicine's authorisation has been withdrawn

bluetongue virus serotype 8
MedicineVeterinaryWithdrawn
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.

български (BG) (1.31 MB - PDF)

View

español (ES) (636.36 KB - PDF)

View

čeština (CS) (706.5 KB - PDF)

View

dansk (DA) (659.36 KB - PDF)

View

Deutsch (DE) (636.58 KB - PDF)

View

eesti keel (ET) (635.16 KB - PDF)

View

ελληνικά (EL) (752.17 KB - PDF)

View

français (FR) (636.97 KB - PDF)

View

hrvatski (HR) (656.66 KB - PDF)

View

italiano (IT) (635.19 KB - PDF)

View

latviešu valoda (LV) (688.95 KB - PDF)

View

lietuvių kalba (LT) (659.14 KB - PDF)

View

magyar (HU) (702.54 KB - PDF)

View

Malti (MT) (732.54 KB - PDF)

View

Nederlands (NL) (635.98 KB - PDF)

View

polski (PL) (729.46 KB - PDF)

View

português (PT) (635.86 KB - PDF)

View

română (RO) (681.7 KB - PDF)

View

slovenčina (SK) (709.46 KB - PDF)

View

slovenščina (SL) (719.53 KB - PDF)

View

Suomi (FI) (635.19 KB - PDF)

View

svenska (SV) (635.66 KB - PDF)

View

Product information

български (BG) (1.51 MB - PDF)

View

español (ES) (901.04 KB - PDF)

View

čeština (CS) (1.24 MB - PDF)

View

dansk (DA) (913.53 KB - PDF)

View

Deutsch (DE) (893.34 KB - PDF)

View

eesti keel (ET) (922.51 KB - PDF)

View

ελληνικά (EL) (1.4 MB - PDF)

View

français (FR) (901.25 KB - PDF)

View

hrvatski (HR) (958.78 KB - PDF)

View

íslenska (IS) (914.86 KB - PDF)

View

italiano (IT) (939.75 KB - PDF)

View

latviešu valoda (LV) (1.27 MB - PDF)

View

lietuvių kalba (LT) (992 KB - PDF)

View

magyar (HU) (1.29 MB - PDF)

View

Malti (MT) (1.28 MB - PDF)

View

Nederlands (NL) (967.17 KB - PDF)

View

norsk (NO) (934.46 KB - PDF)

View

polski (PL) (1.29 MB - PDF)

View

português (PT) (924.18 KB - PDF)

View

română (RO) (994.45 KB - PDF)

View

slovenčina (SK) (1.28 MB - PDF)

View

slovenščina (SL) (1.27 MB - PDF)

View

Suomi (FI) (908.56 KB - PDF)

View

svenska (SV) (911.53 KB - PDF)

View
Latest procedure affecting product information: R/0007
05/06/2015

български (BG) (1.38 MB - PDF)

View

español (ES) (628.23 KB - PDF)

View

čeština (CS) (788.09 KB - PDF)

View

dansk (DA) (657.18 KB - PDF)

View

Deutsch (DE) (617.45 KB - PDF)

View

eesti keel (ET) (653.76 KB - PDF)

View

ελληνικά (EL) (838.45 KB - PDF)

View

français (FR) (650.09 KB - PDF)

View

italiano (IT) (654.14 KB - PDF)

View

latviešu valoda (LV) (801.03 KB - PDF)

View

lietuvių kalba (LT) (695.55 KB - PDF)

View

magyar (HU) (782.34 KB - PDF)

View

Malti (MT) (791.5 KB - PDF)

View

Nederlands (NL) (657.77 KB - PDF)

View

polski (PL) (792.51 KB - PDF)

View

português (PT) (658.03 KB - PDF)

View

română (RO) (686.98 KB - PDF)

View

slovenčina (SK) (791.96 KB - PDF)

View

slovenščina (SL) (782.58 KB - PDF)

View

Suomi (FI) (655.63 KB - PDF)

View

svenska (SV) (650.31 KB - PDF)

View

Product details

Name of medicine
Bovilis BTV8
Active substance
bluetongue virus vaccine, serotype 8 (inactivated)
International non-proprietary name (INN) or common name
bluetongue virus serotype 8
Species
  • Sheep
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI04AA02

Pharmacotherapeutic group

  • Inactivated viral vaccines
  • bluetongue virus
  • SHEEP

Therapeutic indication

Cattle

To stimulate active immunity in sheep from 6 weeks of age against bluetongue virus serotype 8 to reduce viraemia

Sheep

To stimulate active immunity in sheep from 1 month of age against bluetongue virus serotype 8 to prevent viraemia

Authorisation details

EMA product number
EMEA/V/C/000148
Marketing authorisation holder
Intervet International BV

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Marketing authorisation issued
06/09/2010
Revision
4

Assessment history

This page was last updated on

Share this page